Quick Answer
Editas Medicine, Inc. reported Shares Outstanding of 97.87 million shares for fiscal year 2025.
Editas Medicine, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 97.87M | +18.3% |
| 2024 | 82.73M | +1.2% |
| 2023 | 81.77M | +18.8% |
| 2022 | 68.85M | +0.6% |
| 2021 | 68.44M | +9.4% |
| 2020 | 62.56M | +15.1% |
| 2019 | 54.36M | +11.5% |
| 2018 | 48.76M | +9.6% |
| 2017 | 44.51M | +24.3% |
| 2016 | 35.82M | +1007.7% |
| 2015 | 3.23M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 93.26M | +13.0% | +6.7% |
| June 30, 2025 | 87.39M | +6.0% | +4.4% |
| March 31, 2025 | 83.71M | +1.8% | +1.2% |
| December 31, 2024 | 82.73M | +1.2% | +0.2% |
| September 30, 2024 | 82.54M | +1.1% | +0.1% |
| June 30, 2024 | 82.43M | +1.0% | +0.2% |
| March 31, 2024 | 82.23M | +19.2% | +0.6% |
| December 31, 2023 | 81.77M | +18.8% | +0.1% |
- Editas Medicine, Inc. showed an increase of +18.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2015–2025 period, Editas Medicine, Inc.’s shares outstanding has grown by 2926.5% (from 3.23 million shares to 97.87 million shares).
- The most recent figure is from Editas Medicine, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: